{"schema_version":"secwatch.filing_event.v1","accession":"0000070318-22-000047","form_type":"8-K","ticker":"THC","cik":"0000070318","company_name":"TENET HEALTHCARE CORP","filed_at":"2022-10-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.294859+00:00","generated_at":"2026-06-23T02:27:04.670309+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Tenet Q3 net income $131M, adj EPS $1.44; announces $1B buyback; FY22 EBITDA outlook narrowed","bullets":["Q3 net income from continuing ops $131M ($1.16 diluted EPS); adjusted diluted EPS $1.44.","Consolidated Adj. EBITDA $841M vs $855M in Q3 2021; USPI (ambulatory) EBITDA up 16.4% to $319M.","Board authorized $1B share repurchase program expiring Dec 31, 2024.","FY2022 Adj. EBITDA outlook revised to $3.375-$3.475B, ~1% change at midpoint.","Repaid $880M Medicare advances; free cash flow $190M in 9 months (excl. advances $1.07B)."],"urls":{"canonical":"https://secwatch.observer/filing/0000070318-22-000047","json":"https://secwatch.observer/filing/0000070318-22-000047.json","markdown":"https://secwatch.observer/filing/0000070318-22-000047.md","text":"https://secwatch.observer/filing/0000070318-22-000047.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70318/000007031822000047/0000070318-22-000047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70318/000007031822000047/thc-20221020.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T02:27:04.670309+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}